RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Synthesis of C-13-labeled 5-aminoimidazole-4-carboxamide-1-beta-D-[C-13(5)] ribofuranosyl 5 '-monophosphate
Zarkin, A. K., Elkins, P. D., Gilbert, A., Jester, T. L., & Seltzman, H. H. (2018). Synthesis of C-13-labeled 5-aminoimidazole-4-carboxamide-1-beta-D-[C-13(5)] ribofuranosyl 5 '-monophosphate. Journal of Labelled Compounds and Radiopharmaceuticals, 61(11), 820-825. https://doi.org/10.1002/jlcr.3647
5-Aminoimidazole-4-carboxamide-1-beta-D-[C-13(5)] ribofuranosyl 5-monophosphate ([C-13(5) ribose] AICAR-PO3H2) (6) has been synthesized from [C-13(5)]adenosine. Incorporation of the mass-label into [C-13(5) ribose] AICAR-PO3H2 provides a useful standard to aid in metabolite identification and quantification in monitoring metabolic pathways. A synthetic route to the C-13-labeled compound has not been previously reported. Our method employs a hybrid enzymatic, and chemical synthesis approach that applies an enzymatic conversion from adenosine to inosine followed by a ring-cleavage of the protected inosine. A direct phosphorylation of the resulting 2,3-isopropylidine acadesine (5) was developed to yield the title compound in 99% purity following ion exchange chromatography.